Skip to content

A Study on the Use of Medicated Nasal Oil for Managing Hair Fall

Clinical evaluation of efficacy of Yashtyaamalaki Siddha tail nasya in the management of keshapatana with special reference to tricoscopy - Tri nasya trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101085
Enrollment
80
Registered
2026-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L659- Nonscarring hair loss, unspecified

Interventions

None listed

Sponsors

Dr Sapna Sakharam Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of keshpatan Patient with hairfall greater than 50 hair per day or visible thining

Exclusion criteria

Exclusion criteria: Cicatricial alopecia Pregnancy or lactation severe systemic illness and on chemotherapy known allergy to trial drug

Design outcomes

Primary

MeasureTime frame
Yashtyamalaki Siddha Taila Nasya is expected to show clinically and tricoscopically significant improvement in Keshapatana.Timepoint: 1. Treatment period: 1 month. 2.Assessment: 0, 8th, 22nd, and 30th days. 3. Follow up: 45th and 60th day

Secondary

MeasureTime frame
Improvement in hair texture and strength Improvement in hair growth patternTimepoint: reatment period: 1 month. 2.Assessment: 0, 8th, 22nd, and 30th days. 3. Follow up: 45th and 60th day

Countries

India

Contacts

Public ContactDr Sapna Sakharam Patil

mes ayurved mahavidyalaya lote khed ratnagiri

vssw.amv@mespune.in8329030447

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026